Teleflex Announces European Market Clearance for its Arrow® VPS Rhythm™ System

CE mark for Arrow® VPS Rhythm™ System brings cost-effective catheter navigation and tip confirmation to Europe

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced that its Arrow® VPS Rhythm™ System has been issued CE certification from its notified body, the British Standards Institution (BSI), to commercialize the device in the European Union.

The Arrow® VPS Rhythm™ System is a simple and flexible solution that helps take the guesswork out of central catheter procedures by providing ECG-based tip confirmation in a highly portable, lightweight and versatile design. The Arrow® VPS Rhythm™ System with ECG Technology assists in placement and confirmation of the catheter tip in the SVC-CAJ (superior vena cava-cavoatrial junction), and may be used with a broad range of catheter types. When paired with the single-use TipTracker™ Stylet, the Arrow® VPS Rhythm™ System provides real-time navigation, tracing the catheter pathway with a visible blue line on a color screen. Intravascular P-wave changes are saved as the catheter approaches the SVC, helping to identify the lower 1/3 of the SVC, near the CAJ, eliminating the need for confirmatory chest X-ray or fluoroscopy.

“This clearance puts us in a position to establish a cost-effective standard of care in catheter navigation and placement in Europe,” commented Jay White, president and general manager, Vascular Access Division of Teleflex. “Our goal is to make zero complications a reality to improve outcomes and enhance patient and provider safety.”

The Teleflex Vascular Access Division markets a broad range of catheters for vascular access and vascular catheter management technologies, including the Arrow® brand of devices in Europe.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck® – trusted brands united by a common sense of purpose.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex, the Teleflex logo, Arrow, Deknatel, Hudson RCI, LMA, Pilling, Rusch, TipTracker, VPS Rhythm and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. All other trademarks are trademarks of their respective owners.© 2016 Teleflex Incorporated. All rights reserved. MC-002777

View source version on businesswire.com: http://www.businesswire.com/news/home/20161026005103/en/

Teleflex IncorporatedJake ElguiczeTreasurer and Vice President, Investor Relations610-948-2836